Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Legionella pneumonia in a child with leukemia].
Shachor-Meyouhas Y, Arad-Cohen N, Zaidman I, Gefen A, Kassis I. Shachor-Meyouhas Y, et al. Among authors: gefen a. Harefuah. 2012 Aug;151(8):479-82, 496. Harefuah. 2012. PMID: 23350295 Hebrew.
Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study.
Elitzur S, Fischer S, Arad-Cohen N, Barg A, Ben-Harosh M, Danino D, Elhasid R, Gefen A, Gilad G, Levy I, Shachor-Meyouhas Y, Weinreb S, Izraeli S, Barzilai-Birenboim S. Elitzur S, et al. Among authors: gefen a. J Fungi (Basel). 2021 Feb 25;7(3):165. doi: 10.3390/jof7030165. J Fungi (Basel). 2021. PMID: 33668990 Free PMC article.
Improved transplant outcomes with myeloablative conditioning for hemophagocytic lymphohistiocytosis in HLA-matched and mismatched donors: a national multicenter retrospective study.
Greental Ness Y, Kuperman AA, Stein J, Yacobovich J, Even-Or E, Zaidman I, Gefen A, Nevo N, Oberman B, Toren A, Stepensky P, Bielorai B, Jacoby E. Greental Ness Y, et al. Among authors: gefen a. Bone Marrow Transplant. 2021 Sep;56(9):2088-2096. doi: 10.1038/s41409-021-01290-1. Epub 2021 Apr 12. Bone Marrow Transplant. 2021. PMID: 33846559
Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortality.
Zaidman I, Mohamad H, Shalom L, Ben Arush M, Even-Or E, Averbuch D, Zilkha A, Braun J, Mandel A, Kleid D, Attias O, Ben-Ari J, Brooks R, Gefen A, Stepensky P. Zaidman I, et al. Among authors: gefen a. Pediatr Blood Cancer. 2022 Mar;69(3):e29549. doi: 10.1002/pbc.29549. Epub 2021 Dec 30. Pediatr Blood Cancer. 2022. PMID: 34968007
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.
Marsh RA, Rao MB, Gefen A, Bellman D, Mehta PA, Khandelwal P, Chandra S, Jodele S, Myers KC, Grimley M, Dandoy C, El-Bietar J, Kumar AR, Leemhuis T, Zhang K, Bleesing JJ, Jordan MB, Filipovich AH, Davies SM. Marsh RA, et al. Among authors: gefen a. Biol Blood Marrow Transplant. 2015 Aug;21(8):1460-70. doi: 10.1016/j.bbmt.2015.04.009. Epub 2015 Apr 10. Biol Blood Marrow Transplant. 2015. PMID: 25865646 Free PMC article.
356 results